Avestar Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Sell |
18,444
-32
| -0.2% | -$3.75K | 0.13% | 123 |
|
|
2026
Q1 | $2.23M | Buy |
18,476
+958
| +5% | +$111K | 0.14% | 112 |
|
|
2025
Q4 | $1.85M | Sell |
17,518
-1,913
| -10% | -$180K | 0.12% | 136 |
|
|
2025
Q3 | $1.64M | Buy |
19,431
+2,618
| +16% | +$216K | 0.11% | 146 |
|
|
2025
Q2 | $1.34M | Buy |
16,813
+2,954
| +21% | +$235K | 0.09% | 161 |
|
|
2025
Q1 | $1.25M | Sell |
13,859
-4,762
| -26% | -$445K | 0.11% | 159 |
|
|
2024
Q4 | $1.87M | Buy |
18,621
+564
| +3% | +$58.1K | 0.16% | 106 |
|
|
2024
Q3 | $2.06M | Sell |
18,057
-986
| -5% | -$117K | 0.21% | 89 |
|
|
2024
Q2 | $2.36M | Buy |
19,043
+5,320
| +39% | +$685K | 0.24% | 76 |
|
|
2024
Q1 | $1.82M | Buy |
13,723
+2,788
| +25% | +$344K | 0.19% | 104 |
|
|
2023
Q4 | $1.2M | Buy |
10,935
+2,226
| +26% | +$231K | 0.14% | 106 |
|
|
2023
Q3 | $903K | Buy |
8,709
+1,349
| +18% | +$145K | 0.13% | 106 |
|
|
2023
Q2 | $855K | Buy |
7,360
+579
| +9% | +$65.7K | 0.14% | 97 |
|
|
2023
Q1 | $726K | Buy |
6,781
+145
| +2% | +$15.7K | 0.13% | 98 |
|
|
2022
Q4 | $736K | Buy |
6,636
+507
| +8% | +$51.8K | 0.13% | 101 |
|
|
2022
Q3 | $528K | Buy |
6,129
+1,826
| +42% | +$163K | 0.13% | 114 |
|
|
2022
Q2 | $392K | Buy |
4,303
+796
| +23% | +$70.6K | 0.1% | 150 |
|
|
2022
Q1 | $290K | Buy |
3,507
+589
| +20% | +$46.4K | 0.05% | 318 |
|
|
2021
Q4 | $226K | Buy |
2,918
+71
| +2% | +$5.66K | 0.03% | 400 |
|
|
2021
Q3 | $214K | Buy |
2,847
+150
| +6% | +$11.4K | 0.03% | 424 |
|
|
2021
Q2 | $211K | Sell |
2,697
-94
| -3% | -$6.99K | 0.03% | 416 |
|
|
2021
Q1 | $205K | Buy |
2,791
+111
| +4% | +$8.19K | 0.05% | 303 |
|
|
2020
Q4 | $211K | Sell |
2,680
-1,209
| -31% | -$92.5K | 0.06% | 254 |
|
|
2020
Q3 | $293K | Buy |
3,889
+81
| +2% | +$6.34K | 0.1% | 163 |
|
|
2020
Q2 | $283K | Buy |
3,808
+302
| +9% | +$22.7K | 0.13% | 143 |
|
|
2020
Q1 | $260K | Sell |
3,506
-607
| -15% | -$47.7K | 0.14% | 128 |
|
|
2019
Q4 | $356K | Buy |
4,113
+327
| +9% | +$26.9K | 0.2% | 105 |
|
|
2019
Q3 | $304K | Buy |
3,786
+2,106
| +125% | +$169K | 0.19% | 103 |
|
|
2019
Q2 | $128K | Sell |
1,680
-67
| -4% | -$5.13K | 0.08% | 158 |
|
|
2019
Q1 | $131K | Buy |
1,747
+79
| +5% | +$5.91K | 0.09% | 159 |
|
|
2018
Q4 | $118K | Buy |
1,668
+34
| +2% | +$2.4K | 0.08% | 156 |
|
|
2018
Q3 | $105K | Sell |
1,634
-876
| -35% | -$55.8K | 0.06% | 192 |
|
|
2018
Q2 | $138K | Buy |
2,510
+51
| +2% | +$2.88K | 0.09% | 160 |
|
|
2018
Q1 | $120K | Sell |
2,459
-134
| -5% | -$7.24K | 0.08% | 151 |
|
|
2017
Q4 | $130K | Buy |
+2,593
| New | +$144K | 0.1% | 126 |
|
Other funds holding MRK
ECSS
Avestar Capital's MRK Position: Q2 2026 in Review
Avestar Capital reduced its Merck (MRK) stake by 0.17% in Q2 2026, selling an estimated $3.75K and leaving 18,444 shares worth $2.38M. The position accounts for 0.13% of the portfolio, ranked #123.
Avestar Capital first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. 1,863 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Avestar Capital held 18,444 shares of Merck worth $2.38M as of Q2 2026.
- Avestar Capital sold 32 Merck shares in Q2 2026, an estimated $3.75K.
- Merck made up 0.13% of Avestar Capital's portfolio in Q2 2026, its #123 holding.
- Avestar Capital first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- 1,863 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.